Meloxicam Capsule (Meloxicam)

Adult dose

1. Acute exacerbation of osteoarthritis (degenerative joint disease): ○ Adults: Administer 7.5 mg of meloxicam orally once daily. If symptoms do not improve, the dose may be increased to 15 mg daily as needed. 2. Rheumatoid arthritis, ankylosing spondylitis: ○ Adults: Administer 15 mg of this medicine orally once daily. The dose may be reduced to 7.5 mg daily according to response to treatment. Do not administer more than 15 mg of this medicine daily. Take with water or another beverage during a meal. ○ In elderly patients or those at increased risk of adverse reactions, treatment is usually initiated at a dose of 7.5 mg daily. ○ Patients with severe renal impairment receiving hemodialysis should not receive more than 7.5 mg daily.

Individuals who regularly consume three or more glasses of alcohol daily should consult a doctor or pharmacist before taking this medication. Taking it with alcohol can cause gastrointestinal bleeding. This medication may affect the cardiovascular system, so caution is needed for individuals at risk of heart disease or stroke. If such symptoms occur, discontinue use immediately and seek medical attention. There is a risk of serious problems such as gastrointestinal bleeding, ulcers, and perforation, so individuals with a history of gastrointestinal disorders or the elderly should be particularly careful. If gastrointestinal symptoms occur during use, consult medical personnel immediately. This medication can cause severe skin reactions or allergic reactions, so if there are any skin abnormalities, discontinue use and visit a hospital. It may affect kidney and liver function, so individuals with kidney or liver diseases should undergo regular tests and discontinue use if abnormalities are found. Pregnant women or those planning to become pregnant should not take this medication, and breastfeeding women should also avoid it. This medication is not to be given to individuals with specific allergies or diseases, such as aspirin allergy, asthma, severe liver or kidney diseases, and those with active gastrointestinal ulcers. Elderly individuals have a higher risk of adverse reactions due to decreased bodily function, so the lowest effective dose should be used, and they should be carefully monitored. While taking this medication, there may be interactions with other non-steroidal anti-inflammatory drugs, anticoagulants, lithium, methotrexate, etc., so it is essential to inform healthcare providers of all current medications. In case of overdose, severe symptoms such as nausea, vomiting, gastrointestinal bleeding, and renal failure may occur, requiring immediate emergency treatment. No antidote exists; gastric lavage and supportive therapy are necessary. If drowsiness, dizziness, or visual disturbances occur, avoid driving or operating machinery. This medication should be taken at the minimum effective dose for the shortest possible duration, with regular blood tests and checks of liver and kidney function to confirm no abnormalities exist. Keep out of the reach of children and store in the original container with the lid tightly closed.

• Gastrointestinal bleeding
• cardiovascular thrombotic reactions
• myocardial infarction
• stroke
• bleeding from the stomach or intestines
• ulcer
• perforation
• exfoliative dermatitis
• mucous membrane syndrome
• toxic epidermal necrolysis

This medication is sensitive to light and should be stored in a tightly sealed container that blocks light. Additionally, to maintain its effectiveness, it should be stored at room temperature, between 1 to 30 degrees Celsius.

Appearance

Hard capsules with green upper and lower parts filled with light yellow contents

Package unit

30 capsules/bottle, 300 capsules/bottle, 500 capsules/bottle